Srijeeta Mitra

To the Editor, Sickle cell disease (SCD) affects over 300 000 newborns annually, with the highest burden in sub-Saharan Africa and India.1 It imposes a significant financial burden on healthcare systems and affected families.2 Early diagnosis through newborn screening (NBS) and subsequent comprehensive care can reduce under-five mortality by nearly 90% in high-income countries (HICs).3 For NBS to be effective, a positive screening result must be followed by a seamless continuum of care...